The U.S. Food and Drug Administration approved a new indication for the oral drug lenalidomide (brand name Revlimid) as a maintenance therapy for multiple myeloma patients following autologous hematopoietic stem cell transplant (ASCT), also known as autologous blood and marrow transplant (BMT).
Cancer Research
Take it from George Grace: if you’ve smoked your entire life, you listen closely to news about innovative cancer treatments. Grace listened, even before a spot on his lung led to a diagnosis of early-stage non-small cell lung cancer.
The National Cancer Institute (NCI) established an initiative recently that I expect to benefit patients at Roswell Park Cancer Institute (RPCI) and around the country for years to come.
The report released yesterday by the Cancer Moonshot Blue Ribbon Panel, a group convened by Vice President Biden last winter, highlighted some big ideas and high-impact opportunities in oncology.
In 1951, Edwin A. Mirand, PhD, DSc became a permanent employee of Roswell Park Comprehensive Cancer Center. What would have been impossible to know at the time was just how permanent a fixture he would truly become.
Danielle Twum is making it her mission to educate the public about the cutting-edge research taking place at Roswell Park, and how these breakthroughs change the way we treat cancer. The third-year pre-doctoral candidate, studying immunology in Dr. Scott Abrams’ lab, spearheaded her efforts last fall with a compelling presentation at TEDxBuffalo, an independent, local version of TED Talks.
In addition to treating melanoma and sarcoma patients at Roswell Park, Joseph Skitzki, MD, FACS, spent the last few years developing a high-powered, first-of-its-kind microscope for use in the operating room. In February 2016, following a short study of the microscope’s functionality, Dr. Skitzki's research team revealed its stunning findings.
People with Down syndrome have an increased risk of developing very specific types of childhood leukemia, but Eugene Yu, PhD, has an additional reason to focus on the genetic mysteries of Down syndrome.
Roswell Park made national headlines last April in securing an agreement to bring Cuba’s encouraging lung cancer vaccine, CIMAvax, to the United States for clinical testing. Nearly one year later, Cuba is back in the news and CIMAvax is receiving renewed attention. One of the most frequently asked questions about this vaccine is, “When will it be available for lung cancer patients in the U.S.?”
To understand basket trials and why they’re so exciting, take a look at the way most clinical trials are currently designed.
Amid a historic normalizing of relations between the United States and Cuba, a potentially game-changing step was recently taken in the field of lung cancer research.
You’ve probably heard various things about clinical studies — some true, some false — that can impact your decision on whether to participate.